Bridgewater Associates’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-605,782
| Closed | -$25.2M | – | 752 |
|
|
2024
Q4 | $25.2M | Buy |
+605,782
| New | +$25.2M | 0.12% | 140 |
|
|
2024
Q3 | – | Sell |
-15,309
| Closed | -$1.82M | – | 867 |
|
|
2024
Q2 | $1.82M | Buy |
+15,309
| New | +$1.82M | 0.01% | 552 |
|
|
2023
Q3 | – | Sell |
-30,865
| Closed | -$3.75M | – | 788 |
|
|
2023
Q2 | $3.75M | Buy |
30,865
+25,489
| +474% | +$3.1M | 0.02% | 357 |
|
|
2023
Q1 | $826K | Sell |
5,376
-2,301
| -30% | -$353K | 0.01% | 581 |
|
|
2022
Q4 | $1.38M | Sell |
7,677
-9,758
| -56% | -$1.75M | 0.01% | 593 |
|
|
2022
Q3 | $2.06M | Sell |
17,435
-231,722
| -93% | -$27.4M | 0.01% | 557 |
|
|
2022
Q2 | $35.6M | Buy |
249,157
+202,476
| +434% | +$28.9M | 0.15% | 133 |
|
|
2022
Q1 | $8.04M | Buy |
46,681
+43,042
| +1,183% | +$7.41M | 0.03% | 342 |
|
|
2021
Q4 | $924K | Sell |
3,639
-4,670
| -56% | -$1.19M | 0.01% | 589 |
|
|
2021
Q3 | $3.2M | Buy |
+8,309
| New | +$3.2M | 0.02% | 362 |
|